Monday, June 6, 2016

New drug regimens could significantly improve treatment for tuberculosis

›
Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treat...

Melatonin appears to suppress growth of breast cancer stem cells

›
In continuation of my update on Melatonin M elatonin, a hormone produced in the human brain, appears to suppress the growth of breast...
Friday, June 3, 2016

Mycophenolate mofetil drug seems safe, effective in treating autoimmune hepatitis

›
New research indicates that mycophenolate mofetil, a drug that is usually used to prevent rejection after kidney, heart or liver tra...

Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy

›
Previous studies at the University of Colorado Cancer Center show that the experimental drug AMPI-109 potently kills triple-negative b...
Thursday, June 2, 2016

Xalkori Approved For Rare Genetic Form of Lung Cancer

›
In continuation of my update on  Xalkori  (crizotinib) Xalkori  (crizotinib) has been approved by the U.S. Food and Drug Administr...

Teva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington Disease

›
Teva Pharmaceutical Industries Ltd.  announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administr...
Wednesday, June 1, 2016

FDA Grants Spectrum Pharmaceuticals Approval of Evomela (melphalan) for Injection

›
Spectrum Pharmaceuticals,  a biotechnology company with fully integrated commercial and drug development operations with a primary focus i...
Tuesday, May 31, 2016

Organic chemists succeed in synthesizing 3,6-Dihydro-2H-pyran derivatives with high enantiomeric purity

›
The pyran ring is present in so many useful compounds, such as pharmaceuticals (antibiotics, anti-infectives, cardiovascular agents, neurolo...
Monday, May 30, 2016

Allergan Announces FDA Approval of Aczone (dapsone) Gel, 7.5% for Treatment of Acne Vulgaris

›
Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug ...
Friday, May 27, 2016

Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer

›
  Palbociclib  (codenamed  PD-0332991 , trade name  Ibrance ) Pfizer Inc.,  announced that the U.S. Food and Drug Administration (...
Thursday, May 26, 2016

FDA Approves Odefsey (emtricitabine, rilpivirine and tenofovir alafenamide) for the Treatment of HIV-1 Infection

›
Gilead Sciences, Inc announced that the U.S. Food and Drug Administration (FDA) has approved  Odefsey  (emtricitabine 200 mg/rilpivirine 2...
Tuesday, May 24, 2016

FDA Approves Imbruvica (ibrutinib) for the First-Line Treatment of Chronic Lymphocytic Leukemia

›
In continuation of my update on  Ibrutinib   AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the U.S. Foo...
Monday, May 23, 2016

FDA Expands Use of Xalkori (crizotinib) to Treat ROS-1 Positive Non-Small Cell Lung Cancer

›
In continuation of my update on  Xalkori (crizotinib)   The U.S. Food and Drug Administration today approved  Xalkori  ( crizoti...
1 comment:
Friday, May 20, 2016

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

›
In continuation of my update on ibrutinib The U.S. Food and Drug Administration (FDA) has approved IMBRUVICA ®  (ibrutinib) caps...
1 comment:
Thursday, May 19, 2016

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

›
  In continuation of my update  on   Everolimus   Novartis today announced that the United States Food and Drug Administration (FD...